{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:04:18Z","timestamp":1790136258551,"version":"4.0.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Academic Pediatric Infectious Disease NIH Training Grant","award":["T32 HD007233"],"award-info":[{"award-number":["T32 HD007233"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12941-018-0257-x","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T10:44:02Z","timestamp":1519382642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus"],"prefix":"10.1186","volume":"17","author":[{"given":"Benjamin H.","family":"Gern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Greninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Stapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5953-7812","authenticated-orcid":false,"given":"Xuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"257_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1126\/science.99.2579.452","volume":"99","author":"WM Kirby","year":"1944","unstructured":"Kirby WM. Extraction of a highly potent penicillin inactivator from penicillin resistant Staphylococci. Science. 1944;99:452\u20133.","journal-title":"Science"},{"key":"257_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jcp.14.4.385","volume":"14","author":"M Barber","year":"1961","unstructured":"Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961;14:385\u201393.","journal-title":"J Clin Pathol"},{"key":"257_CR3","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJMoa025025","volume":"348","author":"S Chang","year":"2003","unstructured":"Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK, Vancomycin-Resistant Staphylococcus aureus Investigative T. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342\u20137.","journal-title":"N Engl J Med"},{"key":"257_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3201\/eid0702.010204","volume":"7","author":"HF Chambers","year":"2001","unstructured":"Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178\u201382.","journal-title":"Emerg Infect Dis"},{"key":"257_CR5","volume-title":"Performance standards for antimicrobial susceptibility testing. M100-S22","author":"CLSI","year":"2012","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. M100-S22. Wayne: Institute CaLS, Clinical and Laboratory Standards Institute; 2012."},{"key":"257_CR6","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. M100-S23","author":"CLSI","year":"2013","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. M100-S23. Wayne: Institute CaLS, Clinical and Laboratory Standards Institute; 2013."},{"key":"257_CR7","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1128\/AAC.04531-14","volume":"59","author":"K Phe","year":"2015","unstructured":"Phe K, Dao D, Palmer HR, Tam VH. In vitro ceftriaxone susceptibility in methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2015;59:1370.","journal-title":"Antimicrob Agents Chemother"},{"key":"257_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s15010-013-0477-0","volume":"41","author":"SA Winans","year":"2013","unstructured":"Winans SA, Luce AM, Hasbun R. Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone. Infection. 2013;41:769\u201374.","journal-title":"Infection"},{"key":"257_CR9","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","volume":"17","author":"M Paul","year":"2011","unstructured":"Paul M, Zemer-Wassercug N, Talker O, Lishtzinsky Y, Lev B, Samra Z, Leibovici L, Bishara J. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect. 2011;17:1581\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"257_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/cid\/cir857","volume":"54","author":"BW Wieland","year":"2012","unstructured":"Wieland BW, Marcantoni JR, Bommarito KM, Warren DK, Marschall J. A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus. Clin Infect Dis. 2012;54:585\u201390.","journal-title":"Clin Infect Dis"},{"key":"257_CR11","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. M100","author":"CLSI","year":"2017","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. M100. Wayne: Institute CaLS; 2017."},{"key":"257_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/cid\/ciu043","volume":"58","author":"J Dien Bard","year":"2014","unstructured":"Dien Bard J, Hindler JA, Gold HS, Limbago B. Rationale for eliminating Staphylococcus breakpoints for beta-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline. Clin Infect Dis. 2014;58:1287\u201396.","journal-title":"Clin Infect Dis"},{"key":"257_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1159\/000346529","volume":"58","author":"AM Ferreira","year":"2012","unstructured":"Ferreira AM, Bonesso MF, Mondelli AL, Camargo CH, Cunha Mde L. Oxacillin resistance and antimicrobial susceptibility profile of Staphylococcus saprophyticus and other Staphylococci isolated from patients with urinary tract infection. Chemotherapy. 2012;58:482\u201391.","journal-title":"Chemotherapy"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-018-0257-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T19:27:20Z","timestamp":1550604440000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-018-0257-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1186\/s12941-018-0257-x","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"12 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}